All In MedTech

Device Trial Radar · NCT05510661

Use of Export in Primary Percutaneous Coronary Intervention

Use of Export in Primary Percutaneous Coronary Intervention, In-Hospital and Short-term Outcomes and Optimal Time of Export

Last checked: Nov 20, 2026Latest source record: Nov 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 300 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

300

Actual

Start

Jan 15, 2024

Primary completion

Sep 24, 2025

Study completion Apr 17, 2026

Sponsor

Lead sponsor
National Institute of Cardiovascular Diseases, PakistanAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Medtronic
First posted
Aug 22, 2022

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Single (outcomes assessor)
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Aim of this single center randomized open label trial with blinded in-hospital outcomes assessment is designed with aim to compare manual thrombus aspiration followed by percutaneous coronary intervention (PCI) strategy with PCI alone.

Conditions

  • ST-segment Elevation Myocardial Infarction (STEMI)
  • Total Occlusion of Coronary Artery
  • Primary Percutaneous Coronary Intervention

Interventions

  • Export CatheterDevice

    Manual thrombus aspiration with the use of export catheter during primary PCI

  • Balloon catheterDevice

    Predilatation with balloon catheter

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Post thrombus aspiration TIMI flowTime frame: Immediately after export/balloon
  2. Slow/No-reflowTime frame: Immediately after procedure
  3. Major adverse cardiac eventsTime frame: In-hospital, at 1 month, and at 6 months

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • National Institute of Cardiovascular Diseases

    Karachi, Sindh, Pakistan

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.